<DOC>
	<DOCNO>NCT02515747</DOCNO>
	<brief_summary>The purpose study explore role lipoprotein ( ) apolipoprotein ( ) phenotype fatal non-fatal cardiovascular disease ( CVD ) event risk coronary disease patient divide basis management strategy - medical , endovascular open cardiac surgery .</brief_summary>
	<brief_title>Prospective Russian Evaluation Lp ( ) Role cardiovascUlar DiseasE</brief_title>
	<detailed_description>Between January 1993 September 2006 , enrol 1400 consecutive patient Atherosclerosis Department know Lp ( ) level coronary heart disease ( CHD ) verify angiography . In accordance clinical condition angiography data assign three parallel treatment arm follow 15 year . This study conduct accord principle Declaration Helsinki Institutional Ethics Committee .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>stable coronary heart disease verify angiography acute coronary syndrome , acute infection , inflammatory disease within 3 month prior inclusion , familial hypercholesterolemia , triglycerides &gt; 4.5 mmol/L , miss Lp ( ) measurement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Lipoprotein ( )</keyword>
	<keyword>coronary artery bypass grafting ( CABG )</keyword>
	<keyword>apo ( )</keyword>
	<keyword>prognosis</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>cardiovascular death</keyword>
	<keyword>percutaneous coronary intervention ( PCI )</keyword>
</DOC>